New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 24, 2014
13:25 EDTBMRN, BMRN, BMRNLeerink's biotech analyst holds an analyst/industry conference call
Biotech Analyst Schwartz discusses BioMarin's (BMRN) BMN-701 for treatment of Pompe Disease on an Analyst/Industry conference call to be held on January 29 at 2 pm.
News For BMRN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 24, 2014
05:50 EDTBMRNBioMarin remains a top mid cap pick at Piper Jaffray
Subscribe for More Information
October 23, 2014
16:17 EDTBMRNBioMarin lowers FY14 adjusted net loss to ($65M)-($50M) from ($80M)-($60M)
Subscribe for More Information
16:15 EDTBMRNBioMarin raises FY14 revenue view to $700M-$710M from $680M-$700M
Subscribe for More Information
16:13 EDTBMRNBioMarin reports Q3 adjusted EPS (16c), consensus (23c)
Subscribe for More Information
15:30 EDTBMRNNotable companies reporting after market close
Subscribe for More Information
October 21, 2014
09:48 EDTBMRNShire could target BioMarin, TheStreet's Feuerstein says
Subscribe for More Information
October 20, 2014
07:10 EDTBMRNAmerican Society of Human Genetics to hold annual meeting
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use